Astegolimab

Tax included
Astegolimab (MSTT 1041A; RG 6149) is a human IgG2 monoclonal antibody that blocks IL-33 signaling by targeting ST2, the IL-33 receptor. Astegolimab has the potential for chronic obstructive pulmonary disease (COPD) research.
MedChemExpress 
HY-P99444

Data sheet

Size
Multiple sizes
Reactivity
Interleukin Related
CAS
2173054-79-8